Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis.

Cancer Immunol Immunother · 2023 · PMC9628360 · PMID 36315268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Pooled incidence rates showed a trend for febrile neutropaenia and Grade ≥ 3 anaemia occurring more frequently among patients receiving high-dose LD regimens (Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.